Alzheimer's disease severity, objectively determined and measured

Alzheimer's disease severity, objectively determined and measured

Abstract Introduction With expansion of clinical trials to individuals across the spectrum of Alzheimer disease (AD) from preclinical to symptomatic phases, it is increasingly important to quantify AD severity using methods that capture underlying pathophysiology. Methods We derived an AD severity m...

Full description

Bibliographic Details
Main Authors: Alden L. Gross, Dan M. Mungas, Jeannie‐Marie S. Leoutsakos, Marilyn S. Albert, Richard N. Jones, Alzheimer's Disease Neuroimaging Initiative
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Alzheimer's disease
Clinical trials
Measurement
Item response theory
Cognitive testing
Imaging
Online Access:https://doi.org/10.1016/j.dadm.2016.08.005

Internet

https://doi.org/10.1016/j.dadm.2016.08.005

Similar Items